Prevalence of undetected persistent airflow obstruction in male smokers 40-65 years old

Family Practice

Volumn 22, Issue 5, 2005, Pages 485-489

  Geijer, Roeland M M ^a   Sachs, Alfred P E ^a   Hoes, Arno W ^a   Salomé, Philippe L ^a   Lammers, Jan Willem J ^a   Verheij, Theo J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Airflow obstruction; Middle age; Screening; Smokers; Spirometry

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; AIRWAY OBSTRUCTION; ARTICLE; COUGHING; EARLY DIAGNOSIS; GENDER; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SCREENING; SMOKING; SMOKING CESSATION; SPIROMETRY; WORLD HEALTH ORGANIZATION;

ADULT; CROSS-SECTIONAL STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SPIROMETRY; VITAL CAPACITY;

EID: 26444608754     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cmi049     Document Type: Article

References (24)

1. American Thoracic Society. Standards for the diagnosis and care of patients with chronic pulmonary disease. Statement of the American Thoracic Society. Am J Respir Crit Care Med 1995; 152: S77-S120.
2. American Thoracic Society. Cigarette smoking and health. Am J Respir Crit Care Med 1996; 153: 861-865.
3. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: Data form the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000; 160: 1683-1689.
4. Soriano JR, Maier WC, Egger P et al. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax 2000; 55: 789-794.
5. Coultas DB, Mapel D, Gagnon RC, Lydick E. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med 2001; 164: 372-377.
6. Anthonissen NR, Connett JE, Murra RP for the Lung Health Study Research Group. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med 2002; 166: 675-679.
7. Pauwels RA, Buist S, Calverley PMA, Jenkins CR, Hurd SS, on behalf of the GOLD Scientific Committee. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease; NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD). Am J Respir Crit Care Med 2001; 163: 1256-1276.
8. Fabbri LM, Hurd SS, for the GOLD Scientific Committee. Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update. Eur Resp J 2003; 22: 1-2.
9. Stratelis G, Jakobsson P, Molstad S, Zetterstrom O. Early detection of COPD in primary care: Screening by invitation of smokers aged 40 to 55 years. Br J Gen Pract 2004; 54: 201-206.
10. Tzanakis N, Anagnostopoulos U, Filditaki V, Christaki P, Siafakas N, on behalf of the COPD group of the Hellenic Thoracic Society. Prevalence of COPD in Greece. Chest 2004; 125: 892-900.
11. Lundback B, Lindberg A, Lindstrom M et al. Not 15 but 50% of smokers develop COPD? Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2002; 97: 115-122.
12. Clotet J, Gomez-Arbonez X, Ciria C, Albalad JM. Spirometry is a good method for detecting and monitoring chronic obstructive pulmonary disease in high-risk smokers in primary health care. Arch Bronconeumol 2004; 40: 155-159.
13. Van Schayck CP, Loozen JMC, Wagena E, Akkermans RP, Wesseling GJ. Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: Cross sectional case finding study. Br Med J 2002; 324: 1370-1373.
14. Zielinski J, Bednarek M, and Know the Age of Your Lung Study Group. Early detection of COPD in a high-risk population using spirometric screening. Chest 2001; 119: 731-736.
15. Viegi G, Pedreschi M, Pistelli F et al. Prevalence of airways obstruction in a general population. European Respiratory Society vs. American Thoracic Society Definition. Chest 2000; 117: 339S-345S.
16. Sobradelli V, Miravetles M, Gabriel R et al. Geographic variations in prevalence and underdiagnosis of COPD. Results of the IBERPOC multicentre epidemiological study. Chest 2000; 118: 981-989.
17. De Marco, R, Accordini S, Cerveri I et al., for the European Community Respiratory Health Survey (ECRHS) Study Group. An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. Thorax 2004; 59: 120-125.
18. American Thoracic Society. Standardisation of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152: 1107-1136.
19. Hajiro T, Nishimura K, Jones PW et al. A novel, short and simple questionnaire to measure health related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 1874-1878.
20. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC, on behalf of the working party 'Standardisation of lung function testing'. Lung volumes and forced ventilatory flows. Report working party standardisation of lung function tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993; 6(suppl): 5-40.
21. DEFACTO, voor een rookvrije toekomst, jaarverslag 2001. [Dutch Foundation for a smokeless future, year report, 2001.]
22. Kerstjens HAM. The GOLD Classification has not advanced understanding of COPD. Am J Respir Crit Care Med 2004; 170: 21-23.
23. Ferguson GT, Enright PL, Buist AS, Higgins MW. Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program. Chest 2000; 117: 1146-1161.
24. BMA/NHS Confederation. New 2004 GMS contract. www.bma.org.uk/ ap.nsf/content/splashpage